Euclidean Technologies Management Portfolio holdings
Top Buys
| 1 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$2.28M |
| 2 |
Genco Shipping & Trading
GNK
|
+$1.9M |
| 3 |
Metallus
MTUS
|
+$1.89M |
| 4 |
EGLE
Eagle Bulk Shipping Inc.
EGLE
|
+$1.6M |
| 5 |
WIRE
Encore Wire Corp
WIRE
|
+$264K |
Top Sells
| 1 |
Superior Group of Companies
SGC
|
+$1.76M |
| 2 |
Hooker Furnishings Corp
HOFT
|
+$1.53M |
| 3 |
Douglas Dynamics
PLOW
|
+$806K |
| 4 |
Ingles Markets
IMKTA
|
+$436K |
| 5 |
AZZ Inc
AZZ
|
+$417K |
Sector Composition
| 1 | Industrials | 42.41% |
| 2 | Consumer Discretionary | 19.9% |
| 3 | Consumer Staples | 11.29% |
| 4 | Technology | 9.58% |
| 5 | Materials | 6.58% |
Similar funds
Euclidean Technologies Management's Q3 2022 Portfolio in Review
As of Q3 2022, Euclidean Technologies Management held 78 positions worth $89.2M, down 7.9% from $96.8M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Euclidean Technologies Management's Q3 2022 filing shows 5 new, 7 increased, 15 reduced and 11 closed positions. Its largest new stake was Eagle Pharmaceuticals, Inc.: 62,263 shares worth $1.65M. The largest sale was Superior Group of Companies, an estimated $1.76M.
By sector, the portfolio is most concentrated in Industrials at 42% of assets, up from 40% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Euclidean Technologies Management's largest Q3 2022 buy was Eagle Pharmaceuticals, Inc.: 62,263 shares worth $1.65M.
- Euclidean Technologies Management added most to Encore Wire Corp in Q3 2022, an estimated $264K increase.
- Euclidean Technologies Management's biggest Q3 2022 reduction was Ingles Markets, cutting an estimated $436K.
- Euclidean Technologies Management fully exited Superior Group of Companies in Q3 2022, selling an estimated $1.76M.
- Euclidean Technologies Management's ten largest holdings make up 24% of its $89.2M portfolio in Q3 2022.
- Euclidean Technologies Management opened 5 new positions and closed 11 in Q3 2022.
- Euclidean Technologies Management's portfolio value fell 7.9% quarter-over-quarter to $89.2M.
Based on Euclidean Technologies Management's 13F filing for Q3 2022, filed 28 Oct 2022.